DAVIS, Calif., June 14, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, has engaged IR specialists MZ Group (MZ) to manage a comprehensive strategic investor relations and financial communications program across all key markets.
MZ will work closely with Marrone Bio Innovations’ management to develop and execute a comprehensive strategy designed to increase the Company’s visibility throughout the investment community. This structured campaign will highlight Marrone Bio Innovation’s recent business successes along with its strong intellectual property leadership in the biopesticide space.
Marrone Bio Innovations is an industry leader in the rapidly growing biopesticide industry, as its ability to discover and rapidly commercialize novel products is unmatched within the industry. The Company’s ability to “innovate at speed” in a capital-efficient way is atypical within the ag-chem industry and is possible because of the high safety and inherently low risk of biopesticides. As a result of its “dual-use” approach to developing biopesticides with biostimulant properties, Marrone Bio Innovations’ team of scientists have developed products that clearly differentiate the Company within the marketplace.
MZ has developed a distinguished reputation as a premier resource for institutional investors, brokers, analysts and private investors. The firm has six offices across North America, a strong presence in Asia and Brazil, and maintains extensive relationships with investors throughout Europe. Additionally, MZ was recently ranked the No. 1 consultancy in Latin America and No. 7 in the world in business communication.
Managing Director of MZ North America, Greg Falesnik, will be advising Marrone Bio Innovations in all facets of corporate and financial communications, including the coordination of roadshows across key cities and building brand awareness with the financial media.
“Marrone Bio Innovations welcomes its partnership with MZ Group, the world’s largest independent IR firm. Following our strong revenue growth and continued IP innovation across the enterprise, we are partnering with MZ to expand and strengthen our investor relations program,” said Pam Marrone, Marrone Bio Innovation’s Chief Executive Officer. “MZ provides the reach and established track record to develop and enhance our relationships with high quality retail and institutional investors seeking investments in the dynamic and rapidly growing biopesticide space. We are confident that our partnership with MZ will enhance expectations of our investor base.”
Matt Hayden, Chairman of MZ Group North America, commented, “MZ is excited to have the opportunity to partner with a rapidly growing IP leader like Marrone Bio Innovations. After watching the Company concurrently grow both revenues and its intellectual property portfolio over the last few years, we are impressed with what Marrone Bio Innovations has been able to accomplish. Marrone Bio Innovations provides a compelling value proposition to its customer base, which is something that fits well into our client portfolio. We strongly believe Marrone Bio Innovations’ value proposition will resonate well with our investors, and when coupled with execution, will ultimately help grow value for its shareholders.”
About MZ Group
MZ, founded in 1999, combines capital markets intelligence, global investor targeting, IR technology, corporate governance, media and corporate communication and IR consulting, providing comprehensive programs that successfully build and manage shareholder value. With a team of highly experienced senior professionals and an integrated service portfolio, MZ ensures that companies are provided with the right tools and strategies to interact effectively with the investment community and the media, successfully conveying the investment message. MZ's market intelligence, advisory and tactical support activities for investor relations and corporate communications programs are underpinned by a comprehensive IT infrastructure, allowing companies to rapidly achieve global standards of best practices. For more information, please visit www.mzgroup.us.
About Marrone Bio Innovations
Smart. Natural. Solutions.
Marrone Bio Innovations, Inc. (NASDAQ:MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. The Company's effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. The Company has five products for agriculture on the market (Regalia®, Grandevo®, Venerate®, and Majestene® and Haven™), and also distributes Bio-tam 2.0® for Isagro USA in the western U.S. and Jet-Ag® for Jet Harvest in most regions of the U.S. The Company markets Zequanox® for invasive mussels for water markets. Marrone also has a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations, the Company is dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertain-ties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing the Company’s views as of any subsequent date. Examples of such statements include statements regarding the Company’s engagement with MZ, its investor relations and financial communications program and strategy and the Company’s value proposition. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the Company’s products, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, adverse decisions by regulatory agencies and other relevant third parties, and general factors affecting the capital markets. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.